Form 10-Q · Quarterly report
Cigna 10-Q, filed Nov 5, 2026
- Filed
- CIK
- 0001739940
- Accession no.
- 0001739940-26-000071
Summary
Cigna reported third-quarter 2026 total revenues of $73.68 billion, up 6%, while shareholders' net income fell 23% to $1.44 billion, or $5.47 per diluted share, and adjusted income from operations was roughly flat at $2.10 billion. Cigna said its 'Accelerate to One' multi-year enterprise modernization and productivity initiative, announced at its September 2026 investor day, is intended to generate cost savings through 2030, with its existing Strategic Optimization Program continuing as a discrete restructuring program under it.
Key points
- Q3 2026 total revenues rose 6% to $73.68 billion, with pharmacy revenues up 5% and premiums up 9%.
- Shareholders' net income fell 23% for the quarter, which Cigna attributed partly to the absence of an after-tax gain on sale of businesses booked in Q3 2025 and lower net investment performance.
- Evernorth Health Services revenue rose 6% to $63.77 billion and Cigna Healthcare revenue rose 9% to $11.71 billion.
- The consolidated effective tax rate rose to 19.1% from 14.0%, which Cigna linked to the absence of 2025 benefits tied to the HCSC transaction and tax audits.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. MANAGEMENT'S DISCUSSION EXECUTIVE OVERVIEW The Cigna Group, together with its subsidiaries (either individually or collectively referred to as the "Company," "we," "us" or "our"), is a global health company committed to creating a better future for every individual and every community. Our subsidiaries offer a differentiated set of pharmacy, medical, behavioral, dental, and related products and services. For further information on our business and strategy, see Part I, Item 1 - "Business" in our 2025 Form 10-K. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.